Smoking worsens outcomes with advanced colon cancer

April 6, 2013
Smoking worsens outcomes with advanced colon cancer
Smoking is tied to significantly shorter disease-free survival and time to recurrence in patients undergoing treatment for stage III colon cancer, according to a study published April 1 in the Journal of Clinical Oncology.

(HealthDay)—Smoking is tied to significantly shorter disease-free survival (DFS) and time to recurrence (TTR) in patients undergoing treatment for stage III colon cancer, according to a study published April 1 in the Journal of Clinical Oncology.

Amanda Phipps, Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, Wash., and colleagues surveyed patients participating in a randomized adjuvant trial (infusional fluorouracil, leucovorin, and oxaliplatin [FOLFOX] or FOLFOX plus ). A total of 1,968 patients were questioned on smoking history and other risk factors.

The researchers found that ever-smokers experienced significantly shorter DFS, compared with never-smokers (three-year DFS proportion 70 percent versus 74 percent; hazard ratio [HR], 1.21). Even after adjusting for other variables, this association persisted (HR, 1.23), although there was significant interaction in this association based on BRAF mutation status in patients with BRAF wild-type, smoking was associated with shorter DFS (HR, 1.36) but not BRAF mutated (HR, 0.80; 95 percent confidence interval [CI], 0.50 to 1.29) . In those with KRAS mutated versus KRAS wild-type colon cancer there was a stronger associated between smoking and poorer DFS (HR, 1.50 versus HR, 1.09 [95 percent CI, 0.85 to 1.39]), although interaction by KRAS mutation status was not statistically significant (P = .07). Similar associations were seen with TTR analysis.

"Overall, smoking was significantly associated with shorter DFS and TTR in patients with colon cancer," the authors write.
Several authors report to the diagnostics industry.

Explore further: No benefit seen for adjuvant oxaliplatin in stage II colon CA

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

No benefit seen for adjuvant oxaliplatin in stage II colon CA

August 21, 2012
(HealthDay) -- For elderly patients with colon cancer or those with stage II disease, the addition of oxaliplatin to fluorouracil with leucovorin (FL) does not seem to offer any survival benefit, according to a study published ...

Gene-based test identifies poor-prognosis colon cancers

March 9, 2012
(HealthDay) -- A sensitive and specific gene-based classifier can be used to identify BRAF mutant colon cancer tumors and a subpopulation of BRAF wild-type tumors with poor prognosis, according to a study published March ...

Adding drug to chemotherapy following colon cancer surgery does not improve disease-free survival

April 3, 2012
Adding the drug cetuximab to a regimen of drugs used for the treatment of patients following surgery for stage III colon cancer did not result in improved disease-free survival, according to a study in the April 4 issue of ...

KRAS mutations predict shorter survival in lung cancer

July 26, 2012
(HealthDay) -- For patients with advanced lung adenocarcinomas, KRAS mutations predict shorter survival, according to a study published online July 18 in Cancer.

Bevacizumab doesn't prolong survival in stage II-III colon CA

December 12, 2012
(HealthDay)—For patients with stage 2 to 3 colon cancer, the addition of bevacizumab to modified fluorouracil, leucovorin, and oxaliplatin (FOLFOX6) does not prolong disease-free or overall survival, according to a study ...

Obesity linked to worse outcomes in early breast cancer treatment

December 8, 2011
Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Lurker2358
not rated yet Apr 06, 2013
There is nothing good to say about smoking.

Why is this evil habit still legal in the civilized world?

Let's hope marijuana stays banned as well. A federal constitutional amendment ensuring it's illegality would be a good move.
RichMurray
not rated yet Apr 08, 2013
The smoke from a pack of cigarettes (20 grams tobacco) gives 40 mg methanol, the same as from two cans aspartame diet drink -- methanol has a blood half-life of 3 hours and readily enters every cell of the body and the fetus every minute with the bloodstream -- the 20 human tissues with high levels of ADH1 enzyme make methanol into formaldehyde inside cells -- the inner walls of most blood vessels, retina rods and cones, skin and bone marrow fibroblasts, the lining of the GI tract -- humans lack an effective catalyze defense system against this common toxicity, and so are up to a hundred times more vulnerable than any other creature. Did this study check for aspartame use? Other major methanol sources include fresh tomatoes, and unfresh fruits juices vegetables cut up and preserved wet at room temperature in sealed cans jars. Low level daily use of alcohol is a direct antidote to this methanol formaldehyde toxic process, so nondrinkers beware. Search, WC Monte, WhileScienceSleeps

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.